Benzinga reported on Abbott Laboratories' financial expectations while Kevin O'Leary discussed investment strategies, alongside mentions of eBay and Venmo.
1 report, 1 independent
Updated Aug 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Benzinga reported on Abbott Laboratories' financial expectations while Kevin O'Leary discussed investment strategies, alongside mentions of eBay and Venmo.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Abbott Laboratories
American global health care and medical device products company
-
Benzinga
American news channel
-
Kevin O'Leary
Canadian businessman and television personality (born 1954)
Nothing else this week.
Related events
- Benzinga reported on the financial performance of Salesforce, Inc. on May 27, 2026.
- Benzinga is reporting on companies that are listed on the Nasdaq stock exchange.
- Benzinga reported on the financial performance of UnitedHealth Group, while MarketBeat aggregated consensus ratings and target prices.
- Benzinga reports on Wabash National Corporation stock.
- John Delony discussed financial advice on the Benzinga platform.
Coverage
Newest first; wire copies grouped- BenzingaIf You Invested $10K In Abbott Laboratories Stock 10 Years Ago, How Much Would You Have Now? Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Abbot